SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001302448-09-000001
Filing Date
2009-03-10
Accepted
2009-03-10 19:12:22
Documents
1
Period of Report
2009-03-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3914
  Complete submission text file 0001302448-09-000001.txt   5802
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address (650) 808-6000
Shafer Bradford J (Reporting) CIK: 0001302448 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 09670917